Company Filing History:
Years Active: 2018-2019
Title: Innovations of Qi-Qi Feng in Thrombolysis and Antithrombosis
Introduction
Qi-Qi Feng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that exhibit multiple therapeutic activities. His work focuses on innovations that address critical health issues related to thrombolysis and antithrombosis.
Latest Patents
Qi-Qi Feng holds two notable patents. The first patent is titled "Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging." This invention relates to a compound that simultaneously possesses the functions of thrombolysis, free radical scavenging, and thrombus-targeting/antithrombosis. The patent also details the preparation method, composition, and applications of the compound. The second patent, "Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof," shares similar themes and emphasizes the compound's pharmaceutical composition and nanostructure.
Career Highlights
Qi-Qi Feng is associated with Shanghai Lumosa Therapeutics Co., Ltd., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the pharmaceutical industry, particularly in the development of therapeutic agents that target thrombotic conditions.
Collaborations
Qi-Qi Feng collaborates with notable colleagues, including Shi-Qi Peng and Ming Zhao. Their combined expertise enhances the research and development efforts at Shanghai Lumosa Therapeutics Co., Ltd.
Conclusion
Qi-Qi Feng's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work in developing compounds with multiple therapeutic activities is paving the way for new treatments in thrombolysis and antithrombosis.